The challenge: Make and purify a medical isotope that must be used the same day

The challenge: Make and purify a medical isotope that must be used the same day
Remote handling of radioisotopes Credit: UAB

Two radioactive isotopes of the metallic element scandium, or Sc, appear to be ideal for visualizing, and then destroying, solid tumors. A barrier, however, blocks their use—the inability to rapidly produce and purify the isotopes in useful amounts.

The University of Alabama at Birmingham, in conjunction with researchers at the University of Wisconsin and Argonne National Laboratory in Illinois, have received a Department of Energy grant to solve this production roadblock for the radioactive isotopes 43-Sc and 47-Sc. 43-Sc has a half-life of 3.9 hours, so every four hours more than half the radioactivity is lost. It must be used in a PET scan the same day it is made.

43-Sc and 47-Sc are a sought-after "theranostic" pair, says Suzanne Lapi, Ph.D., director of the UAB Cyclotron Facility, professor in the UAB Department of Radiology and leader on the grant.

The neologism "theranostics" combines the words therapy and diagnostics. Both 43-Sc and 47-Sc—if available—would be attached to a targeting peptide to guide them to a solid tumor for imaging and for tumor eradication. 43-Sc would allow a diagnostic scan because it emits positrons resulting in gamma radiation that would travel out of the body for detection and size measurement by a PET scan. 47-Sc would deliver the therapy at the tumor, by emitting a tissue-damaging beta particle.

The Lapi lab at UAB used the UAB cyclotron—a key machine for the development of advanced cancer diagnosis and treatment at the O'Neal Comprehensive Cancer Center at UAB—for preliminary work on how to make the theranostic pair.

They found that protons, fired from the particle accelerator, formed Sc isotopes when using titanium oxide targets. Shaun Loveless, a in the Lapi lab, also developed a purification scheme—target titanium oxide was dissolved in acid and ammonium bifluoride and poured through an ion exchange column to separate Sc from titanium.

Because natural titanium is a mixture of five stable isotopes, these preliminary experiments did not yield pure 43-Sc and 47-Sc. Proton bombardment of natural titanium produced additional, contaminating Sc isotopes. The next step will use targets that are single stable isotopes of titanium, not a mixture.

Researchers at UAB, Wisconsin and Argonne have planned a multipronged production effort. UAB will use its 24 MeV cyclotron to irradiate titanium-46 and titanium-50 targets with protons. Wisconsin will use its 16 MeV cyclotron to irradiate calcium oxide targets with deuteron particles, made of one proton and one neutron. Argonne will irradiate titanium targets with gamma rays.

All three labs will work together, at small scales, to perfect the purification of 43-Sc and 47-Sc from the target materials.

Lapi says UAB's targeting expertise and its powerful cyclotron helped the university compete for the $390,000 research grant. She also says all three sites will involve graduate students in collaborative training and research, which is a goal of the Department of Energy to prepare the future workforce.

The UAB Cyclotron Facility has national recognition. It produces zirconium-89 and other for clinicians and researchers at institutions that include Stanford University, the University of California, MD Anderson Center in Houston, the University of Pennsylvania, Yale University and the Memorial Sloan Kettering Cancer Center in New York.

Also, the UAB cyclotron was part of a surprising, nonmedical basic science discovery published in the journal Nature this year. Lapi and Loveless were co-authors with nuclear physicists working at the Lawrence Livermore National Laboratory in California, City University of New York and the University of Missouri to test the ability of a radioactive zirconium-88 isotope—produced and purified at UAB—to capture neutrons.

Results were eye-opening.

Zirconium 88's ability to capture neutrons was 1 million times greater than the theoretically predicted value, a gap called "surprisingly large" in the study's title. "This is the second-largest thermal neutron capture cross-section ever measured," the authors wrote. "No other cross-section of comparable size has been discovered in the past 70 years."

Explore further

Supplying high-quality cancer-imaging isotopes

Journal information: Nature

Citation: The challenge: Make and purify a medical isotope that must be used the same day (2019, August 21) retrieved 23 May 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors